STAT+: Pharmalittle: U.K. Regulator To Streamline Clinical Trial Approvals; NIH Won’t Seize Patents To Cut Price Of Cancer Drug
The NIH rejected a petition urging the agency to use a controversial provision of federal law to widen access to a cancer drug by forcing the manufacturers to license their…